SCHEDULE 13G FOR TONIX PHARMACEUTICALS HOLDING CORP BY TEHCNOLOGY PARTNERS FUND

Company

Tonix Pharmaceuticals Holding Corp.

Filed

February 19, 2013

Accession Number

0000904454-13-000301

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →